Related Experiment Video
Updated: Aug 3, 2026

06:56
Isolation of Double Negative αβ T Cells from the Kidney
Published on: May 16, 2014
A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice
M Hasegawa1, M Fujimoto, J C Poe
1Department of Immunology, Duke University Medical Center, Durham, NC 27710, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|August 18, 2001
Summary
CD19 deficiency suppresses B cell hyper-responsiveness and autoimmunity seen in Lyn-deficient mice. This study reveals CD19
Area of Science:
- Immunology
- Cell Signaling
- Molecular Biology
Background:
- CD19 and Src family kinases regulate B cell signaling thresholds through cross-talk.
- Lyn kinase is crucial for CD19 phosphorylation, while CD19 amplifies Src kinase activity.
- CD19 deficiency leads to hyporesponsiveness, whereas Lyn deficiency causes hyper-responsiveness and autoimmunity in B cells.
Purpose of the Study:
- To investigate the in vivo interaction between CD19 and Src family kinases in B cell function.
- To determine the impact of combined CD19 and Lyn deficiency on B cell signaling and autoimmunity.
Main Methods:
- Analysis of B cell function in mice deficient for CD19 and Lyn (CD19/Lyn(-/-)).
- Assessment of B cell development, tyrosine phosphorylation, intracellular calcium responses, and immune responses.
- Evaluation of autoantibodies and glomerulonephritis in Lyn-deficient and CD19/Lyn-deficient mice.
Main Results:
- CD19 deficiency reversed the hyper-responsive phenotype and autoimmunity in Lyn(-/-) B cells.
- Combined CD19/Lyn deficiency significantly reduced B1 cell development compared to Lyn deficiency alone.
- Tyrosine phosphorylation of Fyn and other proteins was reduced, while Syk phosphorylation remained normal in CD19/Lyn(-/-) B cells.
- Enhanced intracellular Ca(2+) responses and B cell proliferation were delayed in CD19/Lyn(-/-) B cells.
Conclusions:
- The CD19/Lyn amplification loop is a key regulator of B lymphocyte signal transduction thresholds.
- CD19 also regulates other Src family kinases, influencing B cell function and autoimmunity.
- Targeting CD19 interactions with Src family kinases may offer therapeutic strategies for autoimmune diseases.

